浆细胞疾病患者骨折风险增高与较差的总生存相关
本研究利用英格兰医院 episode 统计(2001–2015年)数据,分析因浆细胞疾病住院患者的骨折发生率及其对总生存的影响。结果显示,浆细胞疾病患者入院后第一年骨折发生率是普通人群的17.8倍,且风险持续长达10年;既往骨折者总生存更差(HR 1.20)。尽管双膦酸盐广泛使用,骨折仍常见且与不良结局相关。
要点
- 浆细胞疾病患者入院后第一年骨折发生率是普通人群的17.8倍,风险持续至首次入院后10年。
- 骨折风险在浆细胞疾病首次入院前即已升高,且骨折后浆细胞疾病发病率增加。
- 既往骨折的浆细胞疾病患者总生存更差(HR 1.20)。
核心结论
- 浆细胞疾病患者骨折风险显著高于普通人群,且骨折与较差的总生存相关,尽管双膦酸盐广泛使用,骨折仍常见并造成显著疾病负担。
研究设计与样本
- 基于英格兰国家登记数据库医院 episode 统计(Hospital Episode Statistics)2001–2015年数据的分析,纳入因浆细胞疾病住院的成人患者。
主要发现
- 浆细胞疾病患者入院后第一年骨折发生率是普通人群的17.8倍,且风险持续至首次入院后10年。
- 骨折风险在浆细胞疾病首次入院前即已升高,且骨折入院后浆细胞疾病发病率增加。
- 浆细胞疾病患者总生存正在改善,但既往骨折患者生存更差(风险比1.20)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pathological fractures are a common complication of plasma cell dyscrasias (PCD) and are associated with significant morbidity. Routine use of bisphosphonates over the past decade has aimed to reduce the risk of fractures in patients with multiple myeloma, but despite this, fractures continue to represent a significant burden of disease. In this study we report the fracture rate of hospital in-patients with PCD in England. Data from the national registry Hospital Episode Statistics between 2001 and 2015 were used to determine fracture rate and its effect on overall survival. Fracture rates were 17·8 times higher than the general population in the first year after admission with PCD, and remained elevated for up to 10 years after first admission. The increased fracture risk preceded the first admission with PCD and, conversely, the incidence of PCD increased after admission with one or more fractures. Overall survival is improving with PCD, however poorer survival is found in patients with a preceding fracture (Hazard ratio 1·20). Despite widespread bisphosphonate use, fractures remain common in PCD, and are associated with poorer outcomes.
引用
- McIlroy G, Mytton J, Evison F, et al. Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survival. Br J Haematol. 2017. PMID: 28653323. doi:10.1111/bjh.14815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。